{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:47:39Z","timestamp":1792615659175,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/ogx.0000000000000029","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T12:27:32Z","timestamp":1392812852000},"page":"89-99","source":"Crossref","is-referenced-by-count":34,"title":["Noninvasive Prenatal Testing"],"prefix":"10.1097","volume":"69","author":[{"given":"Jamie O.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cori D.","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20210212","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(84)90585-3","article-title":"Maternal serum-AFP as screening test for Down syndrome.","volume":"2","author":"Fuhrmann","year":"1984","journal-title":"Lancet"},{"key":"R3-15-20210212","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Downs syndrome in early pregnancy.","volume":"297","author":"Wald","year":"1988","journal-title":"BMJ"},{"key":"R4-15-20210212","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Downs syndrome.","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"R5-15-20210212","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.semperi.2005.05.013","article-title":"First trimester screening: the BUN study.","volume":"29","author":"Wapner","year":"2005","journal-title":"Semin Perinatol"},{"key":"R6-15-20210212","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.347","article-title":"Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY 1 data. National Institute of Child Health and Development Fetal Cell Isolation Study.","volume":"22","author":"Bianchi","year":"2002","journal-title":"Prenat Diagn"},{"key":"R7-15-20210212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum.","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"R8-15-20210212","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.","volume":"62","author":"Lo","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R10-15-20210212","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First-trimester screening for trisomies 21 and 18.","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-15-20210212","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1373\/clinchem.2004.038059","article-title":"Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.","volume":"50","author":"Palomaki","year":"2004","journal-title":"Clin Chem"},{"key":"R12-15-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-200701000-00054","article-title":"ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities.","volume":"109","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R13-15-20210212","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma.","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"key":"R14-15-20210212","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat Diagn"},{"key":"R15-15-20210212","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma.","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R17-15-20210212","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/pd.4156","article-title":"The role of noninvasive prenatal testing as a diagnostic versus a screening toola cost-effectiveness analysis.","volume":"33","author":"Ohno","year":"2013","journal-title":"Prenat Diagn"},{"key":"R18-15-20210212","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect down syndrome: an international clinical validation study.","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"key":"R19-15-20210212","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R20-15-20210212","doi-asserted-by":"crossref","first-page":"137e1","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-Invasive Chromosomal Evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.","volume":"207","author":"Norton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R21-15-20210212","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/des286","article-title":"Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context.","volume":"27","author":"Allyse","year":"2012","journal-title":"Hum Reprod"},{"key":"R22-15-20210212","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.AOG.0000423819.85283.f4","article-title":"545: noninvasive prenatal testing for fetal aneuploidy.","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R23-15-20210212","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/gim.2013.29","article-title":"ACMG statement on noninvasive prenatal screening for fetal aneuploidy.","volume":"15","author":"Gregg","year":"2013","journal-title":"Genet Med"},{"key":"R25-15-20210212","first-page":"415","article-title":"Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy Am J Obstet Gynecol.","volume":"209","author":"Mennuti","year":"2013","journal-title":""},{"key":"R26-15-20210212","first-page":"338","article-title":"Placental mosaicism and intrauterine survival of trisomies 13 and 18.","volume":"44","author":"Kalousek","year":"1989","journal-title":"Am J Hum Genet"},{"key":"R27-15-20210212","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMp1304843","article-title":"A new era in noninvasive prenatal testing.","volume":"369","author":"Morain","year":"2013","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R28-15-20210212","first-page":"22","article-title":"A multi-factorial relationship exists between total circulating cell-free DNA and maternal BMI.","volume":"32","author":"Vora","year":"2012","journal-title":"Prenat Diagn"},{"key":"R29-15-20210212","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1933719108327599","article-title":"Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels.","volume":"16","author":"Lapaire","year":"2009","journal-title":"Reprod Sci"},{"key":"R30-15-20210212","doi-asserted-by":"crossref","first-page":"374e1","DOI":"10.1016\/j.ajog.2012.08.033","article-title":"Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.","volume":"207","author":"Nicolaides","year":"2012","journal-title":"AJOG"},{"key":"R31-15-20210212","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pd.3892","article-title":"DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.","volume":"32","author":"Canick","year":"2012","journal-title":"Prenat Diagn"},{"key":"R33-15-20210212","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ejhg.2008.265","article-title":"Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses.","volume":"17","author":"Forabosco","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"R34-15-20210212","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/ajmg.a.33370","article-title":"Chromosome abnormalities investigated by non-invasive prenatal testing account for approximately 50 of fetal unbalances associated with relevant clinical phenotypes.","volume":"152A","author":"Grati","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R35-15-20210212","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pd.4054","article-title":"Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experience from a single center.","volume":"33","author":"Alamillo","year":"2013","journal-title":"Prenat Diagn"},{"key":"R36-15-20210212","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pd.3886","article-title":"Attitudes toward noninvasive prenatal diagnosis among pregnant women and health professionals in Japan.","volume":"329","author":"Yosumoto","year":"2012","journal-title":"Prenat Diagn"},{"key":"R37-15-20210212","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/pd.2888","article-title":"Noninvasive prenatal diagnosis: pregnant womens interest and expected uptake.","volume":"31","author":"Tischler","year":"2011","journal-title":"Prenat Diagn"},{"key":"R38-15-20210212","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/pd.2835","article-title":"Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation.","volume":"31","author":"Sayres","year":"2011","journal-title":"Prenat Diagn"},{"key":"R39-15-20210212","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/14767058.2013.770464","article-title":"Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.","volume":"26","author":"Song","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R40-15-20210212","first-page":"34","article-title":"Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies.","volume":"15","author":"Garfield","year":"2012","journal-title":"J Manag Care Med"},{"key":"R41-15-20210212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature07517","article-title":"Accurate whole human genome sequencing using reversible terminator chemistry.","volume":"456","author":"Bentley","year":"2008","journal-title":"Nature"},{"key":"R43-15-20210212","doi-asserted-by":"crossref","first-page":"137ra76","DOI":"10.1126\/scitranslmed.3004323","article-title":"Noninvasive whole-genome sequencing of a human fetus.","volume":"4","author":"Kitzman","year":"2012","journal-title":"Sci Transl Med"},{"key":"R44-15-20210212","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature11251","article-title":"Non-invasive prenatal measurement of the fetal genome.","volume":"487","author":"Fan","year":"2012","journal-title":"Nature"}],"container-title":["Obstetrical & Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OGX.0000000000000029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T10:55:47Z","timestamp":1716548147000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-201402000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0000000000000029","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}